Loading clinical trials...
Loading clinical trials...
A Phase III, Multicentre, Randomized, Parallel-group, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Conditions
Interventions
Ocrelizumab
Placebo
Locations
184
United States
Phoenix Neurological Associates Ltd
Phoenix, Arizona, United States
Barrow Neurology Clinic
Phoenix, Arizona, United States
Mayo Clinic- Scottsdale
Scottsdale, Arizona, United States
Arizona Neuroscience Research LLC
Phoenix, Arkansas, United States
Sutter East Bay Medical Foundation
Berkeley, California, United States
MS Center of Southern California
Newport Beach, California, United States
Start Date
March 2, 2011
Primary Completion Date
July 23, 2015
Completion Date
December 31, 2022
Last Updated
January 10, 2024
NCT05359653
NCT06138132
NCT04544449
NCT03455582
NCT04918225
NCT05663853
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions